1.Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa
Kazuki FUJIMOTO ; Narumi MAKI ; Daisuke HASHIBA ; Toshifumi MAEYAMA ; Ryosuke NAKAGAWA ; Hajime ARAI ; Seiji OHTORI
Osteoporosis and Sarcopenia 2023;9(4):137-141
Objectives:
This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism.
Methods:
In this retrospective case series, romosozumab was administered to 5 premenopausal female patients with osteoporosis and anorexia nervosa with fragility fractures. BMD and bone turnover marker changes were investigated at 6 months and 1 year after administering romosozumab.
Results:
BMD increased and high-turnover bone metabolism decreased 6 months and 1 year after administering romosozumab.
Conclusions
Romosozumab is useful for treating osteoporosis in patients with anorexia nervosa.
2.Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
Yuki MORI ; Fumihiko IWAMOTO ; Yasuaki ISHIDA ; Toru KUNO ; Shoji KOBAYASHI ; Takashi YOSHIDA ; Tatsuya YAMAGUCHI ; Tadashi SATO ; Makoto SUDO ; Daisuke ICHIKAWA ; Nobuyuki ENOMOTO
Intestinal Research 2020;18(4):469-475
Behçet’s disease (BD) is a multisystem inflammatory disease of unknown origin. Rarely, BD occurs together with myelodysplastic syndrome (MDS). Interestingly, it is speculated that these are not simple coexistence but that the etiology of intestinal BD is at least partly derived from MDS itself. Furthermore, there is a relationship between MDS in patients with intestinal BD and trisomy 8. Immunosuppressive agents alone are insufficient to control MDS-associated BD, and many of these patients die of infection or hemorrhage. Surgery is considered for intestinal BD patients who are unresponsive to medical treatment or those with bowel complications such as perforation or persistent bleeding. We report a case of intestinal BD associated with MDS and trisomy 8. The patient was unresponsive to oral steroids and immunosuppressive treatment; the patient improved by surgical repair of a bowel perforation. Five years after the surgery, the patient is free of recurrence and not on medication. Our experience suggests that surgery may provide an effective therapeutic option for the treatment of MDS-related BD.
3.Differences in Prevalence of Lymphovascular Invasion among Early Gastric Cancers between Korea and Japan.
Sun Young LEE ; Naohisa YOSHIDA ; Osamu DOHI ; Sang Pyo LEE ; Daisuke ICHIKAWA ; Jeong Hwan KIM ; In Kyung SUNG ; Hyung Seok PARK ; Eigo OTSUJI ; Yoshito ITOH ; Chan Sup SHIM ; Hye Seung HAN ; Mitsuo KISHIMOTO ; Yuji NAITO
Gut and Liver 2017;11(3):383-391
BACKGROUND/AIMS: The presence of invasion is a diagnostic criterion of early gastric cancer (EGC) in Korea, whereas diagnosis in Japan is based on enlarged nuclei and prominent nucleoli. Moreover, the depth of invasion is the location of cancer cell infiltration in Korea, whereas it is the location of lymphovascular invasion (LVI) or cancer cell infiltration in Japan. We evaluated the characteristics of EGC with LVI to uncover the effects of different diagnostic criteria. METHODS: Consecutive T1-stage EGC patients who underwent complete resection were included after endoscopic or surgical resection. The presence of LVI was evaluated. RESULTS: LVI was present in 112 of 1,089 T1-stage EGC patients. LVI was associated with depth of invasion (p<0.001) and age (p=0.017). The prevalence of LVI in mucosal cancer was significantly higher in Korea (p<0.001), whereas that of submucosal cancer was higher in Japan (p=0.024). For mucosal EGC types, LVI was positively correlated with diagnostic criteria applied in Korea (p=0.017). For submucosal EGC types, LVI was positively correlated with Japanese criteria (p=0.001) and old age (p=0.045). CONCLUSIONS: The higher prevalence of LVI for mucosal EGC in Korea and for submucosal EGC in Japan indicates that different diagnostic criteria should be considered when reading publications from other countries.
Asian Continental Ancestry Group
;
Diagnosis
;
Humans
;
Japan*
;
Korea*
;
Prevalence*
;
Stomach Neoplasms*
4.Designing a Program for Learning Health Professions Education
Takuya SAIKI ; Fumiko OKAZAKI ; Takayuki OTO ; Hiraku FUNAKOSHI ; Tomoko MIYOSHI ; Satoru YOSHIDA ; Jun YOSHINO ; Daisuke HIROUCHI
Medical Education 2021;52(6):497-502
This paper outlines the essentials that each organizer of Faculty and Staff Development (FSD) programs in Health Professions Education should focus on when designing a program. The essentials are as follows: the reasons for studying at FDS, the place of practice, content, participants, peers, location, methods, timing, and evidence of learning. These will also help FSD participants think about their perspectives when they choose to participate in the program. It is hoped that more people will get involved in Health Professions Education to increase their knowledge and spice up their daily teaching practice. It is also hoped that those who complete the course will become Faculty Developers in their own areas and professions, revitalizing health professions education and cooperatively increasing the presence of Japanese Health Professions Education.